What is unprecedented is not just the speed and focus with which the community responded to the pandemic but also the singular willingness of scientists all over the world to share new ideas and data immediately and transparently...
If we’re lucky, mutations will make SARS-CoV-2 less lethal, as happened with the 1918 flu—but there’s no guarantee of that
We can learn from parallels between the coronavirus and HIV crises
We now know repeat infections are possible. Understanding them will shape the fight against the pandemic
It’s foolhardy to assume that only some categories of people are at risk
A pioneer in the fight against HIV reflects on the dangers of excess optimism about a coronavirus vaccine
Telescoping testing time lines and approvals may expose all of us to unnecessary dangers
We don’t know for sure, but if we can, it probably won’t be easy, cheap or fast
We need to treat it as the deadly biological threat it is
The antiviral era is upon us, with an array of virus-fighting drugs on the market and in development. Research into viral genomes is fueling much of this progress
By identifying human genes involved in disease, researchers can create potentially therapeutic proteins and speed the development of powerful drugs
HIV is genetically complex. An array of regulatory genes enables it to remain latent or replicate at various rates. This intricate control may underlie key features of the disease
